ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	240.11	221.12	48.23	100.3	7.86	62.33
Cash & Short-Term Investments	247.05	221.12	48.23	100.3	7.86	62.33
Cash Growth	52.78%	358.49%	-51.92%	1175.43%	-87.38%	44.93%
Receivables	166.09	162.08	165.44	128.53	95.79	72.13
Inventory	125.45	111.2	105.36	81.69	60.8	48.16
Prepaid Expenses	13.7	17.2	8.39	7.59	5.86	4
Restricted Cash	-	-	5.01	-	-	-
Other Current Assets	3.17	8.22	11.85	3.67	-	1.08
Total Current Assets	555.46	519.82	344.26	321.78	170.32	187.7
Property, Plant & Equipment	51.64	44.59	43.25	52.67	41.27	40.55
Long-Term Investments	7.4	6.2	8.8	-	-	-
Goodwill	28.22	28.22	28.22	27.89	3.58	3.58
Other Intangible Assets	183.08	209.01	251.64	294.12	188.51	180.39
Long-Term Deferred Tax Assets	89.51	90.71	81.36	67.94	51.7	38.33
Long-Term Deferred Charges	0.3	0.4	-	-	-	-
Other Long-Term Assets	5.15	5.47	2.56	7.21	5.81	6.25
Total Assets	920.75	904.42	760.09	771.6	461.19	456.79
Accounts Payable	48.68	36.68	29.31	22.97	11.26	14.61
Accrued Expenses	55.71	56.28	35.89	27.89	22.92	20.08
Current Portion of Long-Term Debt	0.85	0.85	0.85	0.85	13.24	9.94
Current Portion of Leases	-	1.56	-	-	-	-
Current Income Taxes Payable	-	8.16	-	-	3.91	-
Current Unearned Revenue	-	-	-	-	0.08	0.45
Other Current Liabilities	34.74	41.94	33.4	35.83	27.16	16.6
Total Current Liabilities	139.98	145.48	99.44	87.54	78.57	61.68
Long-Term Debt	284.39	284.82	285.67	286.52	186.55	182.02
Long-Term Leases	4.68	4.11	1.38	-	-	-
Other Long-Term Liabilities	11.09	12.42	35.06	38.8	0.37	0.3
Total Liabilities	440.14	446.82	421.55	412.86	265.49	244
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	532.5	514.1	403.9	387.84	214.35	200.8
Retained Earnings	-65.03	-80.13	-97.29	-47.77	-4.97	17.58
Treasury Stock	-20.04	-10.08	-5.09	-3.14	-2.25	-0.72
Comprensive Income & Other	8.33	8.86	12.17	-3.06	-11.44	-4.87
Total Common Equity	455.76	432.75	313.69	333.89	195.7	212.79
Shareholders' Equity	480.61	457.6	338.54	358.74	195.7	212.79
Total Liabilities & Equity	920.75	904.42	760.09	771.6	461.19	456.79
Total Debt	289.92	291.34	287.9	287.37	199.8	191.96
Net Cash (Debt)	-42.87	-70.22	-239.67	-187.07	-191.93	-129.63
Net Cash Per Share	-2.21	-3.86	-14.74	-14.85	-16.04	-10.77
Filing Date Shares Outstanding	19.52	19.72	16.35	16.55	12	11.9
Total Common Shares Outstanding	19.55	19.12	16.35	16.12	12	11.9
Working Capital	415.48	374.34	244.82	234.24	91.76	126.02
Book Value Per Share	23.31	22.64	19.18	20.71	16.31	17.89
Tangible Book Value	244.46	195.52	33.83	11.88	3.61	28.82
Tangible Book Value Per Share	12.50	10.23	2.07	0.74	0.30	2.42
Land	-	1.55	1.55	5.95	4.67	4.57
Buildings	-	17.88	16.66	19.97	11.63	10.28
Machinery	-	50.41	53.15	46.77	39.11	34.98
Construction In Progress	-	7.69	4.6	2.94	3.39	3.5

Source: S&P Capital IQ. Standard template. Financial Sources.